| __timestamp | Alpine Immune Sciences, Inc. | Summit Therapeutics Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2287709 | 6795238 |
| Thursday, January 1, 2015 | 6844000 | 7454247 |
| Friday, January 1, 2016 | 8586000 | 10345862 |
| Sunday, January 1, 2017 | 6079000 | 16984203 |
| Monday, January 1, 2018 | 8362000 | 16187290 |
| Tuesday, January 1, 2019 | 9467000 | 9299233.54 |
| Wednesday, January 1, 2020 | 10899000 | 19232000 |
| Friday, January 1, 2021 | 14560000 | 23611000 |
| Saturday, January 1, 2022 | 17968000 | 26700000 |
| Sunday, January 1, 2023 | 22222000 | 28215000 |
Cracking the code
In the competitive world of biotechnology, managing costs is crucial for success. This chart compares the Selling, General, and Administrative (SG&A) expenses of Summit Therapeutics Inc. and Alpine Immune Sciences, Inc. from 2014 to 2023. Over this period, Summit Therapeutics consistently outspent Alpine Immune Sciences, with a peak in 2023 where Summit's expenses were approximately 27% higher. Notably, both companies saw a significant rise in SG&A costs, with Alpine's expenses growing nearly tenfold from 2014 to 2023. This trend reflects the increasing investment in administrative and operational capabilities as these companies strive to innovate and expand their market presence. Understanding these financial dynamics offers valuable insights into the strategic priorities and growth trajectories of these biotech firms.
Gilead Sciences, Inc. vs Summit Therapeutics Inc.: SG&A Expense Trends
argenx SE or Alpine Immune Sciences, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Genmab A/S vs Summit Therapeutics Inc. Trends and Insights
Operational Costs Compared: SG&A Analysis of Summit Therapeutics Inc. and PTC Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Summit Therapeutics Inc. and Geron Corporation
Breaking Down SG&A Expenses: Dr. Reddy's Laboratories Limited vs Alpine Immune Sciences, Inc.
SG&A Efficiency Analysis: Comparing Exelixis, Inc. and Alpine Immune Sciences, Inc.
Alpine Immune Sciences, Inc. or CymaBay Therapeutics, Inc.: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: Alpine Immune Sciences, Inc. vs Vericel Corporation
Selling, General, and Administrative Costs: Alpine Immune Sciences, Inc. vs Supernus Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Alpine Immune Sciences, Inc. and Galapagos NV
Cost Management Insights: SG&A Expenses for Alpine Immune Sciences, Inc. and BioCryst Pharmaceuticals, Inc.